千红制药(002550.SZ)：前三季度净利润3.83亿元 同比增加23.79%

Core Viewpoint - Qianhong Pharmaceutical (002550.SZ) reported a slight increase in revenue and a significant rise in net profit for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The company achieved an operating revenue of 1.215 billion yuan, representing a year-on-year increase of 0.61% [1] - The net profit attributable to shareholders reached 383 million yuan, marking a year-on-year increase of 23.79% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 271 million yuan, reflecting an 18.76% year-on-year increase [1] - Basic earnings per share were reported at 0.3066 yuan [1]